Biochemical progression free and overall survival among Black men with stage IV prostate cancer in South Africa: Results from a prospective cohort study
Cancer Medicine · 2024
DOI: 10.1002/cam4.6739 ↗Kurz gefasst
Kohortenstudie in der Zeitschrift Cancer Medicine, 2024. Verfasst von Yoanna S Pumpalova und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, Vagelos College of Physicians and Surgeons, Columbia University, New York City, New York, USA. Hauptthemen laut MEDLINE: Prostatic Neoplasms, Prostate-Specific Antigen, Neoplasm Staging, Androgen Antagonists. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 34 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIH HHS, NCI NIH HHS, Conquer Cancer Foundation.
Abstract (Originalsprache)
Background
Men of African descent are disproportionately affected by prostate cancer (PCa), and many have metastatic disease at presentation. In South Africa (SA), androgen deprivation therapy (ADT) is the first‐line treatment for stage IV PCa.
Objective
To identify predictors of overall survival (OS) in Black South African men with stage IV PCa treated with ADT. Design, Setting, and Participants Men diagnosed with prostate cancer (3/22/2016–10/30/2020) at Chris Hani Baragwanath Academic Hospital in Soweto, Johannesburg, were recruited for the Men of African Descent with Cancer of the Prostate study. We included men with newly diagnosed stage IV PCa treated with ADT who had a prostate‐specific antigen (PSA) level drawn prior to initiation of ADT and had ≥1 PSA drawn ≥12 weeks after ADT start. Outcomes Measures and Statistical Analysis We used Kaplan–Meier statistics to estimate OS and Cox regression models to identify predictors of OS. Results and Limitations Of the 1097 men diagnosed with prostate cancer, we included 153 men with stage IV PCa who received ADT and met PSA requirements. The median age was 68.0 years (interquartile range 64–73 years). Median OS from time of ADT initiation was 3.39 years (95% confidence interval (CI): 3.14%–noncalculable), while biochemical progression‐free survival was 2.36 years (95% CI: 2.03%–3.73%). Biochemical progression (HR 3.52, 95% CI: 1.85%–6.70%), PSA nadir level >4 ng/mL (HR 3.77, 95% CI: 1.86%–7.62%), alkaline phosphatase level at diagnosis >150 IU/dL (HR 3.09, 95% CI: 1.64%–5.83%), and hemoglobin at diagnosis
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Medicine, Vagelos College of Physicians and Surgeons, Columbia University, New York City, New York, USA.
- Department of Epidemiology, Mailman School of Public Health, Columbia University, New York City, New York, USA.
- Strengthening Oncology Services Research Unit, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa.
- Division of Urology, Department of Surgery, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa.
- National Cancer Registry, National Health Laboratory Service, Johannesburg, South Africa.
- Sydney Brenner Institute for Molecular Bioscience, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa.
ORCID-Profile: Yoanna S Pumpalova, Timothy R Rebbeck
Förderung
- NIH HHS
- NCI NIH HHS
- Conquer Cancer Foundation
- National Institutes of Health
Zitieren
APA
Pumpalova, Y. S., Ramakrishnan, A., May, M., Pentz, A., Minkowitz, S., Doherty, S., Singh, E., Chen, W. C., Rebbeck, T. R., Neugut, A. I., & Joffe, M. (2024). Biochemical progression free and overall survival among Black men with stage IV prostate cancer in South Africa: Results from a prospective cohort study. Cancer Medicine. https://doi.org/10.1002/cam4.6739
Vancouver
Pumpalova YS, Ramakrishnan A, May M, Pentz A, Minkowitz S, Doherty S, et al. Biochemical progression free and overall survival among Black men with stage IV prostate cancer in South Africa: Results from a prospective cohort study. Cancer Medicine. 2024. doi:10.1002/cam4.6739
BibTeX
@article{Pumpalova2024,
author = {Pumpalova, Yoanna S and Ramakrishnan, Adarsh and May, Michael and Pentz, Audrey and Minkowitz, Shauli and Doherty, Sean and Singh, Elvira and Chen, Wenlong Carl and Rebbeck, Timothy R and Neugut, Alfred I and Joffe, Maureen},
title = {Biochemical progression free and overall survival among Black men with stage IV prostate cancer in South Africa: Results from a prospective cohort study},
journal = {Cancer Medicine},
year = {2024},
doi = {10.1002/cam4.6739}
}
EUVIMED